Role of Radiotherapy in Modern Treatment of Hodgkin's Lymphoma - Wikidata - wikimedia - TriplyDB

Role of Radiotherapy in Modern Treatment of Hodgkin's Lymphoma

Role of Radiotherapy in Modern Treatment of Hodgkin's Lymphoma

http://www.wikidata.org/entity/Q34235785

about

The histone variant H2A.Bbd is enriched at sites of DNA synthesis.Secondary Neoplasms in Children with Hodgkin's Lymphoma Receiving C-MOPP and Radiotherapy: Presentation of Four Cases.Quality of life amongst lymphoma survivors in a developing country.Patient preferences for oropharyngeal cancer treatment de-escalation.Oncologists’ Perspectives on Consolidation Radiation Treatment after Chemotherapy for Lymphomas: A Survey Study by the Lymphoma Working Committee of the Turkish Oncology Group (TOG)

P2860

Q33698689-D38345B5-70CF-4A4C-9B7D-747F2337B898 Q36722784-66DB0895-4129-4222-8180-927C2900CD5F Q40513610-76D90A3C-3BD2-4AD3-9909-749261EAB1A4 Q45378293-AF768343-763B-43BE-BDD6-4044B229CBC7 Q47207408-2BC52189-8263-4453-8DEA-EC22DF4D39A5

P2860

Role of Radiotherapy in Modern Treatment of Hodgkin's Lymphoma

http://www.wikidata.org/entity/Q34235785

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Role of Radiotherapy in Modern Treatment of Hodgkin's Lymphoma

@ast

Role of Radiotherapy in Modern Treatment of Hodgkin's Lymphoma

@en

Role of Radiotherapy in Modern Treatment of Hodgkin's Lymphoma

@nl

type

label

Role of Radiotherapy in Modern Treatment of Hodgkin's Lymphoma

@ast

Role of Radiotherapy in Modern Treatment of Hodgkin's Lymphoma

@en

Role of Radiotherapy in Modern Treatment of Hodgkin's Lymphoma

@nl

prefLabel

Role of Radiotherapy in Modern Treatment of Hodgkin's Lymphoma

@ast

Role of Radiotherapy in Modern Treatment of Hodgkin's Lymphoma

@en

Role of Radiotherapy in Modern Treatment of Hodgkin's Lymphoma

@nl

P1433

Q34235785-3224051D-05D0-4112-8BF1-85A19507D827

P1476

Q34235785-785618D1-B6C5-49CD-B5E5-99B3764EEDD8

P2093

Q34235785-57CF5EF8-50D8-4A10-BC6E-38B66AD6BE86

Q34235785-C433D024-F42F-4CF3-BE7D-9E89FA8ECD8E

P2860

Q34235785-0D709E81-1CB0-4DC3-8D4E-A214D05C85A4

Q34235785-14AB2E16-1B87-4AF1-9852-47A097D0EB65

Q34235785-1D4750E6-3C1C-4D19-9092-8D7AA61CF7E8

Q34235785-256E5D97-BA63-44B4-8C20-B52941FEEF51

Q34235785-259C469F-A675-4282-AD6B-EF9F88F826DD

Q34235785-277596C0-B919-4802-98FA-57A09445BFA9

Q34235785-3099C1F7-EC6B-408E-88F6-6E455B3368C3

Q34235785-3425149F-EA70-48FB-A584-5FA06A299512

Q34235785-3BA5EDB1-345B-4239-9E27-7CFDC4EEDACC

Q34235785-450B8258-1A94-4F5E-81B1-E20E2824900C

P304

Q34235785-DBD8C6C6-583E-47AC-B346-DB0B8DD9EAFB

P31

Q34235785-B9F815F9-6526-4FF4-97D3-B4CF24CF919B

P356

Q34235785-130D591A-7C85-44A0-8953-951E294CB2B5

P478

Q34235785-D9AFCFD3-1E62-4A9F-9227-4AB59598757D

P577

Q34235785-3A68E227-F119-4CA7-AB04-BABB3106DFEF

P5875

Q34235785-35D51BF7-7C5B-453B-A297-596BF597FB36

P698

Q34235785-F1A19C34-0F5D-47C9-928C-86212FD0B466

P921

Q34235785-1991FB4A-8C94-47D4-A2F5-1D05F8A7FCCE

P932

Q34235785-CB809F1B-E3D3-4999-A9ED-DCC522DE7F13

P356

P1433

Advances in Hematology

P1476

Role of Radiotherapy in Modern Treatment of Hodgkin's Lymphoma

@en

P2093

Kheng-Wei Yeoh

http://www.w3.org/2001/XMLSchema#string

N George Mikhaeel

http://www.w3.org/2001/XMLSchema#string

P2860

Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood

Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD

Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP

ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi

Twenty years of MOPP therapy for Hodgkin's disease

Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy

Combined modality treatment improves tumor control and overall survival in patients with early stage Hodgkin's lymphoma: a systematic review.

A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model.

Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's

Consolidation radiotherapy in patients with advanced Hodgkin's lymphoma: survival data from the UKLG LY09 randomized controlled trial (ISRCTN97144519).

P304

258797

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2011/258797

http://www.w3.org/2001/XMLSchema#string

P478

2011

http://www.w3.org/2001/XMLSchema#string

P577

2010-10-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47567102

http://www.w3.org/2001/XMLSchema#string

P698

20981157

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

2963126

http://www.w3.org/2001/XMLSchema#string